Literature DB >> 20146783

Rest premature ventricular contractions on routine ECG and prognosis in heart failure patients.

Vy-Van Le1, Teferi Mitiku, David Hadley, Jonathan Myers, Victor F Froelicher.   

Abstract

BACKGROUND: Premature ventricular contractions (PVC) at rest are frequently seen in heart failure (HF) patients but conflicting data exist regarding their importance for cardiovascular (CV) mortality. This study aims to evaluate the prognostic value of rest PVCs on an electrocardiogram (ECG) in patients with a history of clinical HF. METHODS AND
RESULTS: We considered 352 patients (64 + or - 11 years; 7 females) with a history of clinical HF undergoing treadmill testing for clinical reasons at the Veterans Affairs Palo Alto Health Care System (VAPAHCS) (1987-2007). Patients with rest PVCs were defined as having > or = 1 PVC on the ECG prior to testing (n = 29; 8%). During a median follow-up period of 6.2 years, there were 178 deaths of which 76 (42.6%) were due to CV causes. At baseline, compared to patients without rest PVCs, those with rest PVCs had a lower ejection fraction (EF) (30% vs 45%) and the prevalence of EF < or = 35% was higher (75% vs 41%). They were more likely to have smoked (76% vs 55%).The all-cause and CV mortality rates were significantly higher in the rest PVCs group (72% vs 49%, P = 0.01 and 45% vs 20%, P = 0.002; respectively). After adjusting for age, beta-blocker use, rest ECG findings, resting heart rate (HR), EF, maximal systolic blood pressure, peak HR, and exercise capacity, rest PVC was associated with a 5.5-fold increased risk of CV mortality (P = 0.004). Considering the presence of PVCs during exercise and/or recovery did not affect our results.
CONCLUSION: The presence of PVC on an ECG is a powerful predictor of CV mortality even after adjusting for confounding factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20146783      PMCID: PMC6932718          DOI: 10.1111/j.1542-474X.2009.00340.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  30 in total

Review 1.  Electrocardiographic arrhythmia risk testing.

Authors:  Gregory Engel; James G Beckerman; Victor F Froelicher; Takuya Yamazaki; Henry A Chen; Kelly Richardson; Ryan J McAuley; Euan A Ashley; Sung Chun; Paul J Wang
Journal:  Curr Probl Cardiol       Date:  2004-07       Impact factor: 5.200

2.  Severe frequent ventricular ectopy after exercise as a predictor of death in patients with heart failure.

Authors:  James O O'Neill; James B Young; Claire E Pothier; Michael S Lauer
Journal:  J Am Coll Cardiol       Date:  2004-08-18       Impact factor: 24.094

3.  Prognostic significance of ventricular ectopic activity in survivors of acute myocardial infarction.

Authors:  J B Kostis; R Byington; L M Friedman; S Goldstein; C Furberg
Journal:  J Am Coll Cardiol       Date:  1987-08       Impact factor: 24.094

4.  Approaches to sudden death from coronary heart disease.

Authors:  B Lown; M Wolf
Journal:  Circulation       Date:  1971-07       Impact factor: 29.690

5.  Ventricular arrhythmias in severe heart failure: incidence, significance, and effectiveness of antiarrhythmic therapy.

Authors:  C S Chakko; M Gheorghiade
Journal:  Am Heart J       Date:  1985-03       Impact factor: 4.749

6.  Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era. GISSI-2 results.

Authors:  A P Maggioni; G Zuanetti; M G Franzosi; F Rovelli; E Santoro; L Staszewsky; L Tavazzi; G Tognoni
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

7.  The relationships among ventricular arrhythmias, left ventricular dysfunction, and mortality in the 2 years after myocardial infarction.

Authors:  J T Bigger; J L Fleiss; R Kleiger; J P Miller; L M Rolnitzky
Journal:  Circulation       Date:  1984-02       Impact factor: 29.690

8.  Value of ambulatory electrocardiographic monitoring to identify increased risk of sudden death in patients with left ventricular dysfunction and heart failure.

Authors:  B M Szabó; D J van Veldhuisen; H J Crijns; A C Wiesfeld; H L Hillege; K I Lie
Journal:  Eur Heart J       Date:  1994-07       Impact factor: 29.983

9.  Comparison of one-, six- and 24-hour ambulatory electrocardiographic monitoring for ventricular arrhythmia as a predictor of mortality in survivors of acute myocardial infarction. CAMIAT Pilot Study Group. Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.

Authors:  S J Connolly; J A Cairns
Journal:  Am J Cardiol       Date:  1992-02-01       Impact factor: 2.778

10.  Relationships among ventricular arrhythmias, coronary artery disease, and angiographic and electrocardiographic indicators of myocardial fibrosis.

Authors:  R M Califf; J M Burks; V S Behar; J R Margolis; G S Wagner
Journal:  Circulation       Date:  1978-04       Impact factor: 29.690

View more
  4 in total

Review 1.  The year of 2010 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-04       Impact factor: 1.468

2.  Frequency of Ventricular Arrhythmias and Other Rhythm Abnormalities in Children and Young Adults With the Marfan Syndrome.

Authors:  Douglas Y Mah; Lynn A Sleeper; Jane E Crosson; Richard J Czosek; Barry A Love; Brian W McCrindle; Laura Muiño-Mosquera; Aaron K Olson; Thomas A Pilcher; Elif Seda Selamet Tierney; Maully J Shah; Stephanie B Wechsler; Luciana T Young; Ronald V Lacro
Journal:  Am J Cardiol       Date:  2018-07-17       Impact factor: 2.778

3.  Modifiable Predictors of Ventricular Ectopy in the Community.

Authors:  Tuomas Kerola; Thomas A Dewland; Eric Vittinghoff; Susan R Heckbert; Phyllis K Stein; Gregory M Marcus
Journal:  J Am Heart Assoc       Date:  2018-11-20       Impact factor: 5.501

4.  Diagnostic and prognostic significance of premature ventricular complexes in community and hospital-based participants: A scoping review.

Authors:  Sukardi Suba; Kirsten E Fleischmann; Hildy Schell-Chaple; Priya Prasad; Gregory M Marcus; Xiao Hu; Michele M Pelter
Journal:  PLoS One       Date:  2021-12-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.